Once-a-Week Versus Once-Every-3-Weeks Cisplatin Chemoradiation for Locally Advanced Head and Neck Cancer: A Phase III Randomized Noninferiority TrialVanita Noronha, Kumar Prabhash, Atanu Bhattacharjee et al.|Journal of Clinical Oncology|2017Cited by 340
A randomized phase 3 trial comparing nimotuzumab plus cisplatin chemoradiotherapy versus cisplatin chemoradiotherapy alone in locally advanced head and neck cancerVijay Patil, Manish Pandey, Vanita Noronha et al.|Cancer|2019Cited by 133
Phase III randomized trial comparing weekly versus three-weekly (W3W) cisplatin in patients receiving chemoradiation for locally advanced head and neck cancer.Vanita Noronha, Kumar Prabhash, Amit Joshi et al.|Journal of Clinical Oncology|2017Cited by 26
Distress Screening in Head and Neck Cancer Patients Planned for Cancer‐Directed RadiotherapyShirley Lewis, Jai Prakash Agarwal, Saket Pandey et al.|The Laryngoscope|2021Cited by 20
Definitive and adjuvant radiation therapy for external auditory canal and temporal bone squamous cell carcinomas: Long term outcomesSarbani Ghosh Laskar, Jai Prakash Agarwal, Shwetabh Sinha et al.|Radiotherapy and Oncology|2022Cited by 14